Based on 1 analysts giving stock ratings to Aptevo Therapeutics Inc in the past month.
In the current month, APVO has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APVO average Analyst price target in the last month is 25.500.
Based on analysts' estimates, APVO EPS is projected to reach -3.715 in FY2026Q3, following reported EPS of -5.313 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -5.31, while Aptevo Therapeutics IncAPVO's earnings per share (EPS) for the previous quarter was USD -6.41. EPS for the next quarter is expected at USD -3.71.